Controversies
December 19, 2024
Challenging the CHAGASICS Trial December 19, 2024
Exposing the failures of peer review, Dr. Anis Rassi Jr. MD, PhD, recently published his letter to JAMA Cardiology in Sensible Medicine about glaring issues with the CHAGASICS trial. The story began with Dr. Rassi expressing his concerns to the study’s editor at JAMA who advised him to submit a formal letter to JAMA’s Editor-in-Chief […]
Structural Heart
December 16, 2024
Capstan’s Robotic MR/TR Frontier Funding December 16, 2024
Capstan Medical took a key step towards its vision of launching the first robotic cardiac valve surgery system, landing $110M in Series C funding. Focusing on mitral and tricuspid valve diseases, Capstan’s treatment combines transcatheter implantation of a folded valve replacement with its X-ray and ultrasound-guided robot to align the low-profile implant with the beating […]
Cholesterol Reduction
December 12, 2024
NewAmsterdam’s BROADWAY Show December 12, 2024
Topline results from NewAmsterdam’s Phase 3 BROADWAY trial provided the strongest evidence yet of obicetrapib’s potential for patients with ASCVD and heterozygous familial hypercholesterolemia (HeFH) who can’t lower their LDL-C with statins. The BROADWAY trial randomized ~2.5k patients to take obicetrapib or placebo (2:1 ratio) and monitored them over a 52-week follow up period. BROADWAY […]
